Horizon Therapeutics
KRYSTEXXA
Manufacturer:
Horizon Therapeutics
Name:
KRYSTEXXA
Category:
J Code
HCPCS:
J2507
NDC(s):
75987-0080-10,
Primary Type:
Rheumatologic
Route of Administration:
Intravenous
About:
KRYSTEXXA is a Rheumatologic drug manufactured by Horizon Therapeutics and administered via the Intravenous route of administration. The J Code: J2507 is aligned to the drug KRYSTEXXA.